MGL-3196 - VIA-3196

Based on 30 reference(s) in Google Scholar 10 10 30

Axon 2657

CAS [920509-32-6]

MF C17H12Cl2N6O4
MW 435.22

  • Purity: 99%
  • Soluble in DMSO
Recently added

MGL-3196

Description

Oral, liver-targeted, selective thyroid hormone receptor β-agonist (EC50 value 0.21 µM for THR-β) that is being developed for the treatment of dyslipidemia. MGL-3196 is 28-fold selective for THR-β over THR-α in an in vitro functional coactivator recruitment assay.

KEYWORDS: MGL-3196 | supplier | THR-β agonist | VIA-3196 | MGL3196 | VIA3196 | CAS [920509-32-6] | Triiodothyronine | thyroid hormone receptor | THR | NR1A | nuclear receptor | dyslipidemia | HDL | LDL | cholesterol | cardiovascular | diabetes | hypercholesterolemic

Order
Size Unit Price Stock
5 mg €105.00 In Stock
25 mg €365.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €160.00 In Stock
2 x 25 mg €560.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...